A detailed history of Clari Vest Asset Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 12 shares of GILD stock, worth $1,056. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Previous 11 9.09%
Holding current value
$1,056
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$63.15 - $72.88 $63 - $72
1 Added 9.09%
12 $0
Q1 2024

May 06, 2024

SELL
$71.58 - $87.29 $10,092 - $12,307
-141 Reduced 92.76%
11 $0
Q4 2023

Feb 13, 2024

BUY
$73.27 - $83.09 $73 - $83
1 Added 0.66%
152 $12,000
Q3 2023

Nov 13, 2023

SELL
$73.94 - $80.67 $2,513 - $2,742
-34 Reduced 18.38%
151 $11,000
Q1 2023

May 08, 2023

BUY
$77.31 - $88.08 $2,628 - $2,994
34 Added 22.52%
185 $15,000
Q4 2022

Feb 14, 2023

BUY
$62.32 - $89.47 $5,484 - $7,873
88 Added 139.68%
151 $12,000
Q3 2022

Nov 10, 2022

BUY
$59.54 - $68.01 $476 - $544
8 Added 14.55%
63 $4,000
Q1 2022

May 04, 2022

BUY
$57.92 - $72.58 $695 - $870
12 Added 27.91%
55 $4,000
Q2 2020

Aug 12, 2020

BUY
$72.34 - $84.0 $434 - $504
6 Added 16.22%
43 $3,000
Q1 2020

May 04, 2020

BUY
$62.63 - $80.22 $2,317 - $2,968
37 New
37 $2,000
Q4 2017

Feb 13, 2018

SELL
$71.15 - $83.52 $253,792 - $297,915
-3,567 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$72.11 - $85.47 $38,362 - $45,470
532 Added 17.53%
3,567 $289,000
Q2 2017

Nov 20, 2017

BUY
N/A
3,035
3,035 $215,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.